Literature DB >> 28792913

Iron in neurodegenerative disorders: being in the wrong place at the wrong time?

Sotirios Apostolakis1, Anna-Maria Kypraiou1.   

Abstract

Brain iron deposits have been reported consistently in imaging and histologic examinations of patients with neurodegenerative disorders. While the origins of this finding have not been clarified yet, it is speculated that impaired iron homeostasis or deficient transport mechanisms result in the accumulation of this highly toxic metal ultimately leading to formation of reactive oxygen species and cell death. On the other hand, there are also those who support that iron is just an incidental finding, a by product of neuronal loss. A literature review has been performed in order to present the key findings in support of the iron hypothesis of neurodegeneration, as well as to identify conditions causing or resulting from iron overload and compare and contrast their features with the most prominent neurodegenerative disorders. There is an abundance of experimental and observational findings in support of the hypothesis in question; however, as neurodegeneration is a rare incident of commonly encountered iron-associated disorders of the nervous system, and this metal is found in non-neurodegenerative disorders as well, it is possible that iron is the result or even an incidental finding in neurodegeneration. Understanding the underlying processes of iron metabolism in the brain and particularly its release during cell damage is expected to provide a deeper understanding of the origins of neurodegeneration in the years to come.

Entities:  

Keywords:  Alzheimer’s disease; CNS; Parkinson’s disease; iron overload; neurodegeneration

Mesh:

Substances:

Year:  2017        PMID: 28792913     DOI: 10.1515/revneuro-2017-0020

Source DB:  PubMed          Journal:  Rev Neurosci        ISSN: 0334-1763            Impact factor:   4.353


  16 in total

1.  The Impact of Inhaled Ambient Ultrafine Particulate Matter on Developing Brain: Potential Importance of Elemental Contaminants.

Authors:  Deborah A Cory-Slechta; Marissa Sobolewski; Elena Marvin; Katherine Conrad; Alyssa Merrill; Tim Anderson; Brian P Jackson; Gunter Oberdorster
Journal:  Toxicol Pathol       Date:  2019-10-14       Impact factor: 1.902

2.  Dexmedetomidine Promotes SH-SY5Y Cell Resistance Against Impairment of Iron Overload by Inhibiting NF-κB Pathways.

Authors:  Xi-Bei Hu; Zhi-Yu Xi; Lin-Qing Liu; Kai Kang; Wan-Hong Li; Yu-Xian Shen; Fang Kang; Juan Li
Journal:  Neurochem Res       Date:  2019-01-29       Impact factor: 3.996

Review 3.  The Integrated Stress Response and Phosphorylated Eukaryotic Initiation Factor 2α in Neurodegeneration.

Authors:  Sarah Bond; Claudia Lopez-Lloreda; Patrick J Gannon; Cagla Akay-Espinoza; Kelly L Jordan-Sciutto
Journal:  J Neuropathol Exp Neurol       Date:  2020-02-01       Impact factor: 3.685

4.  Increased Brain Iron Deposition in the Putamen in Patients with Type 2 Diabetes Mellitus Detected by Quantitative Susceptibility Mapping.

Authors:  Jing Li; Qihao Zhang; Nan Zhang; Lingfei Guo
Journal:  J Diabetes Res       Date:  2020-09-25       Impact factor: 4.011

Review 5.  The Neuromelanin Paradox and Its Dual Role in Oxidative Stress and Neurodegeneration.

Authors:  Alexandra Moreno-García; Alejandra Kun; Miguel Calero; Olga Calero
Journal:  Antioxidants (Basel)       Date:  2021-01-16

6.  Increased Brain Iron Detection by Voxel-Based Quantitative Susceptibility Mapping in Type 2 Diabetes Mellitus Patients With an Executive Function Decline.

Authors:  Jing Li; Qihao Zhang; Nan Zhang; Lingfei Guo
Journal:  Front Neurosci       Date:  2021-01-15       Impact factor: 4.677

Review 7.  Iron metabolism in diabetes-induced Alzheimer's disease: a focus on insulin resistance in the brain.

Authors:  Ji Yeon Chung; Hyung-Seok Kim; Juhyun Song
Journal:  Biometals       Date:  2018-07-24       Impact factor: 2.949

Review 8.  New Perspectives in Iron Chelation Therapy for the Treatment of Neurodegenerative Diseases.

Authors:  Marco T Nuñez; Pedro Chana-Cuevas
Journal:  Pharmaceuticals (Basel)       Date:  2018-10-19

9.  Peroxiredoxin 5 deficiency exacerbates iron overload-induced neuronal death via ER-mediated mitochondrial fission in mouse hippocampus.

Authors:  Dong Gil Lee; Min Kyoung Kam; Sang-Rae Lee; Hong Jun Lee; Dong-Seok Lee
Journal:  Cell Death Dis       Date:  2020-03-23       Impact factor: 8.469

Review 10.  Iron Metabolism, Ferroptosis, and the Links With Alzheimer's Disease.

Authors:  Nao Yan; JunJian Zhang
Journal:  Front Neurosci       Date:  2020-01-29       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.